Sanofi's consumer health care results factored so little in its latest quarter that it wouldn’t have mentioned a brand in the category if not for its pending relaunch of OTC heartburn remedy Zantac with famotidine as the active ingredient.
Sanofi Returning Zantac OTC Heartburn Remedy Brand To US Market Formulated With Famotidine
Consumer Health Gets Little Mention In Q1 Results After Sales Dip 7%
Along with its Q1 results including a 7.3% drop in consumer health sales to €1.11bn ($1.35bn), Sanofi announces 10-mg famotidine tablets branded Zantac 360° will be available in the US in June.